Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 1.66 is 24% below its 5-year average of 2.18, near the low end of its 5-year range (1.44–4.76).
As of the fiscal period ended Tuesday, June 30, 2026. 22.25% below its 12-month average of 2.13.
Reported quarterly current ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 1.66.
CURRENT RATIO
1.66
CURRENT RATIO AVG TTM
2.13
CURRENT RATIO AVG 3Y
2.22
CURRENT RATIO AVG 5Y
2.18
CURRENT RATIO AVG 10Y
N/A
CURRENT RATIO AVG 15Y
N/A
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-22.25%
CURRENT VS 3Y AVG
-25.53%
CURRENT VS 5Y AVG
-24.11%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.75
median of 874 covered companies
CURRENT VS SECTOR MEDIAN
-55.84%
vs the sector median at left
Market Cap
$35.47M
Current Ratio
2.77
TTM Avg
2.09
3Y Avg
1.85
5Y Avg
2.65
Market Cap
$35.06M
Current Ratio
7.07
TTM Avg
2.75
3Y Avg
16.37
5Y Avg
28.22
Market Cap
$33.93M
Current Ratio
11.47
TTM Avg
9.93
3Y Avg
10.68
5Y Avg
16.03
Market Cap
$36.42M
Current Ratio
3.10
TTM Avg
1.66
3Y Avg
0.84
5Y Avg
1.97
Market Cap
$36.29M
Current Ratio
0.18
TTM Avg
0.18
3Y Avg
0.32
5Y Avg
0.43
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| DocGo Inc. (DCGO) | $35.32M | 1.66 | 2.13 | 2.22 | 2.18 |
| Elicio Therapeutics, Inc. (ELTX)vs › | $35.47M | 2.77 | 2.09 | 1.85 | 2.65 |
| BriaCell Therapeutics Corp. (BCTX)vs › | $35.06M | 7.07 | 2.75 | 16.37 | 28.22 |
| Elutia Inc (ELUT)vs › | $34.04M | 1.77 | 1.46 | 1.21 | 1.48 |
| Edesa Biotech, Inc. (EDSA)vs › | $36.17M | 2.76 | 5.79 | 4.84 | 5.49 |
| Grace Therapeutics, Inc. (GRCE)vs › | $33.93M | 11.47 | 9.93 | 10.68 | 16.03 |
| QT Imaging Holdings, Inc. (QTI)vs › | $36.42M | 3.10 | 1.66 | 0.84 | 1.97 |
| EUDA Health Holdings Limited (EUDA)vs › | $36.29M | 0.18 | 0.18 | 0.32 | 0.43 |
| Scilex Holding Company (SCLX)vs › | $33.63M | 0.07 | 0.12 | 0.27 | 0.25 |
| Aligos Therapeutics, Inc. (ALGS)vs › | $33.54M | 2.19 | 3.38 | 4.17 | 5.03 |
Current Ratio
1.66
Quick Ratio
1.66
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-06-30 | 1.66 |
| 2026-03-31 | 1.79 |
| 2025-12-31 | 2.26 |
| 2025-09-30 | 2.59 |
| 2025-06-30 | 2.36 |
| 2025-03-31 | 2.44 |
| 2024-12-31 | 2.50 |
| 2024-09-30 | 2.19 |
| 2024-06-30 | 2.13 |
| 2024-03-31 | 2.09 |
| 2023-12-31 | 1.99 |
| 2023-09-30 | 2.36 |
| 2023-06-30 | 2.56 |
| 2023-03-31 | 2.37 |
| 2022-12-31 | 2.71 |
| 2022-09-30 | 3.54 |
| 2022-06-30 | 4.76 |
| 2022-03-31 | 4.40 |
| 2021-12-31 | 4.42 |
| 2021-09-30 | 1.44 |
| 2021-06-30 | 1.66 |
| 2021-03-31 | 2.02 |
| 2020-12-31 | 2.49 |
| 2020-09-30 | 0.02 |
| 2020-06-30 | 0.00 |
| 2020-03-31 | 0.00 |
